Trump, Medicare

15 Costly Medicare Drugs Selected for Next Round of Price Negotiations
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T
Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.
Where $2 prescription drug prices, Obamacare stand in Trump executive order onslaught
Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 generic drugs for $2 a month, according to another executive order signed on Trump's first day in his new term.
What Has Trump Done on Prescription Drug Prices?
An early move by the president has raised questions about what direction his second-term policy on drug costs will take.
Trump Order Didn’t Reverse All of Biden’s Measures to Lower Drug Costs
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for lowering drug costs. Trump's action didn't affect the caps on seniors' drug costs or Medicare price negotiations that Biden signed into law.
Trump Rescinds Biden Order on Drug Costs: Impact Explained
Amidst political shifts, President Trump revoked a Biden-era directive aimed at reducing prescription drug costs, raising questions about future policies. Under Biden's order, the Department of Health and Human Services (HHS) was tasked with exploring ways to cut medication expenses for Medicare and Medicaid,
CBS News on MSN13d
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
US govt looks to bring 'greater transparency' in Medicare drug price negotiations
The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...
CNN on MSN13d
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
USA TODAY on MSN13d
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
The Hill on MSN13d
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, ...
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
BioPharma Dive17h
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...